Stocks · News reference

Processa Pharmaceuticals shares are trading lower after the company announced a $200 million private placement and acquisition of Vidya Therapeutics BTK Inhibitor VT-7208.

Jul 29, 2026, 12:52 PMBenzinga Newsdesk

Reference details

Connected markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

Keep reading

SEC EDGARAug 4, 2026, 9:25 PMSEC EDGAR
8-K filing — Processa Pharmaceuticals, Inc. (PCSA)
Filed: 2026-08-04 AccNo: 0001493152-26-036032 Size: 226 KB Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers Item 5.07: Submission of Matters to a Vote of Security Holders Item 9.01: Financial Statements and Exhibits
Read original at edgar
PCSA
BenzingaJul 29, 2026, 4:02 PMAvi Kapoor
Crude Oil Surges 7%; General Dynamics Posts Upbeat Earnings
Dow Jones falls 800+ pts; energy shares up 2.6%; General Dynamics beats earnings estimates; Verra Mobility reaches agreement with Avis.
Read original at benzinga
BAND GD HURN MANH PCSA
BenzingaJul 29, 2026, 1:46 PMAvi Kapoor
Dow Tumbles 400 Points; Procter & Gamble Shares Fall After Q4 Results
US stocks mostly lower, Dow Jones falls 400+ pts. Energy shares up 3%. Procter & Gamble shares down 4% after worse-than-expected sales & EPS. Asian markets mixed.
Read original at benzinga
AMIX NCRA PCSA PG PSN